DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Jorgensen KK, Olsen IC, Goll GL. et al.
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.

Lancet 2017;
389: 2304-2316

Jorgensen KK, Olsen IC, Goll GL. et al.
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.

Lancet 2017;
389: 2304-2316

Download Bibliographical Data

Search in:
Access: